Gilead Sciences (NASDAQ: GILD) STOCK RECOMMENDATION
Idea | BUY |
Buy Range | 86 – 88 |
Target | 92 – 93 |
StopLoss* | below 84.5 |
Duration | 12-14 Trading Days |
Potential Returns | 5% – 6% |
Idea | Buy Range | Target | StopLoss* | Duration | Potential Returns |
BUY | 86 – 88 | 92 – 93 | below 84.5 | 12-14 Trading Days | 5% – 6% |
* Once the first target hit, reset the StopLoss at your buying price.
Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview. Be assured such records are permanent and irreversible.
Gilead Sciences (NASDAQ: GILD) STOCK OVERVIEW
Gilead Sciences, Inc. is a biopharmaceutical firm focused on discovering, developing, and marketing medicines for unmet medical needs globally, including the U.S. and Europe. It offers products like Biktarvy, Genvoya, and Truvada for HIV/AIDS, Veklury for COVID-19, and Epclusa for viral hepatitis. Additionally, it provides Yescarta and Tecartus for oncology, Letairis for pulmonary arterial hypertension, and AmBisome for serious fungal infections. The company collaborates with various firms, including Arcus Biosciences and Merck, and has a research agreement with Merus N.V. Founded in 1987, it is based in Foster City, California.
Stock Data | |
NASDAQ Symbol | GILD |
Sectoral Index | Health Care |
52 Weeks High | 88.36 |
52 Weeks Low | 62.07 |
Gilead Sciences (NASDAQ: GILD) - RELATIVE STRENGTH

Relative Performance - Last 1 Year
Gilead Sciences — NASDAQ —
Gilead Sciences (NASDAQ: GILD) - DAILY TECHNICAL ANALYSIS

- After facing a significant rejection around the 90 level, the stock price fell and entered a phase of consolidation.
- During this extended consolidation, the stock has developed a Descending Broadening pattern.
- Following a recent breakout, the price is poised for a substantial upward movement.
Gilead Sciences (NASDAQ: GILD) - RSI

- Current RSI of this stock is 70.41, which indicates the strength of buyers.
Gilead Sciences (NASDAQ: GILD) - EMA Cross

- The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last dayโs candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.
Gilead Sciences (NASDAQ: GILD) - ADX & DI

- Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
CONCLUSION - Gilead Sciences (NASDAQ: GILD) STOCK PRICE FORECAST
Based on our stock trading advice in USA, Gilead Sciences stock price target will be USD 92 – USD 93 in the next 12-14 trading sessions.